effects [qlco]
Conventional [qlco]
Doses [qnco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
effects [qlco]
Hormone replacement therapy [topp]
Affect [menp]
Aspect [qnco]
Relevant [qlco]
Cardiovascular disease [dsyn]
Including [ftcn]
Vasomotor function [ortf]
Inflammation [patf]
Haemostasis [ortf]
Current [tmco]
Doses [qnco]
Hormone replacement therapy [topp]
exert [orgf]
Mixture [sbst]
adverse effects [ftcn]
Current [tmco]
Study [mnob]
Compared [acty]
effects [qlco]
Doses [qnco]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Conventional [qlco]
Doses [qnco]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Variety [cnce]
Relevant [qlco]
CARDIOVASCULAR [bdsy]
Parameters [fndg]
Methods [inpr]
thi [euka]
randomized [resa]
Double-Blind Study [resa]
cross over [genf]
included [ftcn]
Women [popg]
Received [qlco]
Progesterone 100 MG [clnd]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
Hormone replacement therapy [topp]
mg% [qnco]
Hormone replacement therapy [topp]
Daily [tmco]
2 Months [tmco]
Hormone replacement therapy [topp]
effects [qlco]
Hormone replacement therapy [topp]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglyceride level [lbtr]
Low density lipoprotein cholesterol level [lbpr]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Improved [qlco]
Percent [qnco]
Flow [npop]
mediated response [menp]
Dilator [medd]
Hyperaemia [patf]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
Degree [qlco]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Increased [qnco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Decreased antithrombin III [fndg]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Increased [qnco]
Prothrombin fragment 1+2 [aapp, bacs]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
fragment [ftcn]
P NOS [aapp, imft]
Interest [menp]
effects [qlco]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Antithrombin III [aapp, phsu]
fragment [ftcn]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Reduced [qlco]
Plasma [bdsu]
PAI-1 [aapp, bacs]
antigen levels [lbpr]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
P NOS [aapp, imft]
Degree [qlco]
P NOS [aapp, imft]
Conclusions [idcn]
Compared [acty]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
effects [qlco]
Lipoproteins [aapp, bacs]
Flow [npop]
mediated [socb]
Dilation [patf]
PAI-1 [aapp, bacs]
antigen levels [lbpr]
Hormone replacement therapy [topp]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
fragment [ftcn]
Levels [qlco]
Decreased [qnco]
Antithrombin III [aapp, phsu]
Hormone replacement therapy [topp]
